Evidence map›Paper›PMID 37884959›Full record

ArticleJournal of neuroinflammation2023

IL-1R1 signaling in TBI: assessing chronic impacts and neuroinflammatory dynamics in a mouse model of mild closed-head injury.

Jonathan C Vincent, Colleen N Garnett, James B Watson, Emma K Higgins, Teresa Macheda, Lydia Sanders, Kelly N Roberts, Ryan K Shahidehpour, Eric M Blalock, Ning Quan and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. CSF1R and IL1R1 inhibitors synergistically attenuate the early pathogenesis of traumatic brain injury in mice.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jonathan C VincentDepartment of Neuroscience, University of Kentucky, 741 S. Limestone St., Lexington, KY, 40536, USA.
Colleen N GarnettDepartment of Neuroscience, University of Kentucky, 741 S. Limestone St., Lexington, KY, 40536, USA.
James B WatsonDepartment of Neuroscience, University of Kentucky, 741 S. Limestone St., Lexington, KY, 40536, USA.
Emma K HigginsDepartment of Neuroscience, University of Kentucky, 741 S. Limestone St., Lexington, KY, 40536, USA.
Teresa MachedaDepartment of Neuroscience, University of Kentucky, 741 S. Limestone St., Lexington, KY, 40536, USA.
Lydia SandersDepartment of Neuroscience, University of Kentucky, 741 S. Limestone St., Lexington, KY, 40536, USA.
Kelly N RobertsDepartment of Neuroscience, University of Kentucky, 741 S. Limestone St., Lexington, KY, 40536, USA.
Ryan K ShahidehpourDepartment of Neuroscience, University of Kentucky, 741 S. Limestone St., Lexington, KY, 40536, USA.
Eric M BlalockDepartment of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, USA.
Ning QuanDepartment of Biomedical Science, Charles E. Schmidt College of Medicine and Brain Institute, Florida Atlantic University, Jupiter, FL, USA.
Adam D BachstetterDepartment of Neuroscience, University of Kentucky, 741 S. Limestone St., Lexington, KY, 40536, USA. adam.bachstetter@uky.edu.
University of Kentucky · USFlorida Atlantic University · USUniversity of Alabama at Birmingham · US

Funding

Neurobiology of CNS Injury and RepairT32NS077889 · NINDS · UNIVERSITY OF KENTUCKY · PI Warren Joseph Alilain, JOHN C GENSEL · 2012 to 2026
$2.4M
Training in Translational Research in Alzheimer's and Related Dementias (TRIAD)T32AG078110 · NIA · UNIVERSITY OF KENTUCKY · PI Michael Paul Murphy, LINDA J VAN ELDIK · 2022 to 2026
$2.3M
Neuroinflammation, Neuronal IL-1R1, and BehaviorR01NS116914 · NINDS · FLORIDA ATLANTIC UNIVERSITY · PI Ning Quan · 2020 to 2026
$2.2M
Neuronal IL-1R1 Signaling in Mild Closed Head InjuryR01NS120882 · NINDS · UNIVERSITY OF KENTUCKY · PI ADAM D BACHSTETTER, Christopher Mark Norris · 2022 to 2026
$2.1M
Cell-Specific Actions of IL-1 / IL-1R1 Signaling Following Traumatic Brain InjuryR01NS103785 · NINDS · UNIVERSITY OF KENTUCKY · PI BACHSTETTER, ADAM D · 2019 to 2023
$1.6M
Understanding the immune response after mild TBI: Do endothelial cells play a major role?F31NS116912 · NINDS · UNIVERSITY OF KENTUCKY · PI BODNAR, COLLEEN · 2020 to 2021
$87k
NIA NIH HHS T32 AG078110NIA NIH HHS T32AG078110NINDS NIH HHS F31 NS116912NINDS NIH HHS F31NS116912NINDS NIH HHS R01 NS103785NINDS NIH HHS R01 NS116914NINDS NIH HHS R01 NS120882NINDS NIH HHS T32 NS077889
6 · The paper itself

Abstract

Neuroinflammation contributes to secondary injury cascades following traumatic brain injury (TBI), with alternating waves of inflammation and resolution. Interleukin-1 (IL-1), a critical neuroinflammatory mediator originating from brain endothelial cells, microglia, astrocytes, and peripheral immune cells, is acutely overexpressed after TBI, propagating secondary injury and tissue damage. IL-1 affects blood-brain barrier permeability, immune cell activation, and neural plasticity. Despite the complexity of cytokine signaling post-TBI, we hypothesize that IL-1 signaling specifically regulates neuroinflammatory response components. Using a closed-head injury (CHI) TBI model, we investigated IL-1's role in the neuroinflammatory cascade with a new global knock-out (gKO) mouse model of the IL-1 receptor (IL-1R1), which efficiently eliminates all IL-1 signaling. We found that IL-1R1 gKO attenuated behavioral impairments 14 weeks post-injury and reduced reactive microglia and astrocyte staining in the neocortex, corpus callosum, and hippocampus. We then examined whether IL-1R1 loss altered acute neuroinflammatory dynamics, measuring gene expression changes in the neocortex at 3, 9, 24, and 72 h post-CHI using the NanoString Neuroinflammatory panel. Of 757 analyzed genes, IL-1R1 signaling showed temporal specificity in neuroinflammatory gene regulation, with major effects at 9 h post-CHI. IL-1R1 signaling specifically affected astrocyte-related genes, selectively upregulating chemokines like Ccl2, Ccl3, and Ccl4, while having limited impact on cytokine regulation, such as Tnfα. This study provides further insight into IL-1R1 function in amplifying the neuroinflammatory cascade following CHI in mice and demonstrates that suppression of IL-1R1 signaling offers long-term protective effects on brain health.

Indexed as

Brain Injuries, TraumaticHead Injuries, ClosedReceptors, Interleukin-1 Type IAnimalsCytokinesEndothelial CellsInflammationInterleukin-1MiceMice, Inbred C57BLMicrogliaNeuroinflammatory DiseasesCytokinesIL1R1 protein, mouseInterleukin-1Receptors, Interleukin-1 Type IAstrocyteInterleukin-1Interleukin-1 receptor-1MicrogliaNeuroinflammationTraumatic brain injury

Identifiers

PMID37884959
PMCPMC10601112
OpenAlexW4387965940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.